CLOs on the Move

Celleration Inc

www.celleration.com

 
Celleration Inc is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Eden Prairie, MN. To find more information about Celleration Inc, please visit www.celleration.com
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million
  • www.celleration.com
  • 10250 Valley View Rd Ste 137
    Eden Prairie, MN USA 55344-3577
  • Phone: 952.224.8700

Executives

Name Title Contact Details

Similar Companies

Medcillary

At Medcillary, we provide the latest ancillary products and services that benefit patients and healthcare providers to meet and exceed their unique needs. We are passionate about developing innovative, ground-breaking tests, products and tools to enhance patient care, provide value to our clients, and transform information into knowledge and insights. Our goal is to advance the development and delivery of healthcare and consumer products by providing the highest quality testing possible. Mission: Medcillary was founded with two key principles in place: compliance and clinical relevance with a focus on offering superior and innovative healthcare products aligned to meet the needs of the physicians in our communities, while leading the way for business development and operational excellence through honesty and integrity with our strategic partners. Our vision is to be the most successful and respected medical ancillary solution company in the world. Our core values are: - Commitment - Integrity - Transparency - Pursuit of Excellence - Customer Focus - Respect

Eurotech Tables/Manufacturing

Eurotech Tables/Manufacturing is a Osage Beach, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Animal Derm Clinic

Animal Dermatology Group is a veterinary dermatology specialty company with the worlds largest unified group of veterinary dermatology specialists engaged in the diagnosis and treatment of acute and chronic skin conditions in pets.

NavigatorMD

NavigatorMD, Inc. was founded in 2005 to address the rising demand for an integrated data analysis and health plan management solution. As an insurance broker, Ernest Youngblood, founder of NavigatorMD, watched the progressive increase in health care costs and identified the opportunity for organizations to save money while improving the overall wellness of a plan population. Youngblood led the organization of a multi-disciplinary team of healthcare professionals, ranging from physicians and pharmacologists to benefit consultants and C-Suite executives to develop its first product, Design180®. The intended purpose of this advisory team was to establish an understanding of the problems and hurdles that faced the business community in managing and understanding their health claims spend. This unique insight and knowledge was the basis of its technically sound, business-oriented approach to claims analysis and comprehensive health plan management. NavigatorMD launched its first product in 2008 with the mission of lowering health care costs and adding value to health plans by focusing on manageable costs and utilizing the power of data. Influenced by the concept of value-based insurance design, our health claims data analytics software was created under the advisory of various professionals, including former VP of Strategic H.R. Initiatives at Pitney Bowes, David Hom, who served as an early member of the NavigatorMD's Board of Directors. Early success and escalating interest in the product resulted in the formation of an advisory board comprising several influential experts in the field of Value-Based Insurance Design (VBID). In addition, NavigatorMD received support and referrals from two of the largest pharmaceutical companies in the U.S. that were responsible for funding the development of the Center for Value Based Health Management, among other value-based health care initiatives. NavigatorMD, the first step toward proactive health plan management.  

Isoflux Biomed

Isoflux Biomed is a Rochester, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.